|
|
Paradox Discovered About General Anesthesia: It Can Increase Post-Surgical Pain
|
|
The general anesthesia that puts patients into unconscious sleep so they do not feel surgical pain can increase the discomfort they feel once they wake up, say researchers from Georgetown University Medical Center. |
|
| |
|
Fibromyalgia Stumps Doctors
|
|
Physicians are often slow to diagnose fibromyalgia, and multiple reasons may account for the delay, new data suggest.
|
|
| |
|
One Year After Heart Attack, Chest Pain Remains For Many
|
|
About 20% of heart attack patients experience angina (chest pain) one year after the major cardiac event, according to researchers who have published a new study in the June 23 issue of Archives of Internal Medicine. |
|
| |
|
New Study Finds Oral Cannabis Ineffective In Treating Acute Pain
|
|
A study published in the July issue of the Journal Anesthesiology discovered that oral cannabis (a form of medical marijuana) not only failed to alleviate certain types of pain in human volunteers but, surprisingly, it instead caused increased sensitivity to some forms of pain. |
|
| |
|
Vitamin D A Surprising Champion Of Back Pain Relief, Report Says
|
|
Up to 8 out of 10 persons will have back pain in their lifetimes. In many cases, such pains are chronic lasting more than 3 months and there is no evidence of any injury, disease, or bone problem like a slipped disk |
|
| |
|
First Results For Phase IIa Data Of UCB's Lacosamide For Treatment Of Fibromyalgia
|
|
UCB announced headline results based on first-line analyses of its Phase IIa clinical trial with lacosamide to treat fibromyalgia syndrome. The initial results from this proof of concept study showed activity of lacosamide in fibromyalgia syndrome but require further analysis. |
|
| |
|
Actemra Is First Biologic Agent To Show Better Efficacy Than Methotrexate In RA
|
|
PARIS: The interleukin-6 receptor inhibitor Actemra (tocilizumab) achieves significantly greater reduction in the signs and symptoms of rheumatoid arthritis (RA) than the current standard of care, methotrexate, according to two international clinical trials reported this week at EULAR 2008, the Annual European Congress of Rheumatology.
|
|
| |
|
Medicines Derived From Cannabis: A Review Of Adverse Events
|
|
Researchers at the McGill University Health Centre (MUHC), McGill University and the University of British Columbia (UBC) determined that medical use of cannabinoids do not cause an increase in serious adverse events, but are associated with an increase in some non-serious adverse events.
|
|
| |
